Chapter 22. Past Evolution and Future Prospects of the Pharma Industry and its Regulation in the USA

  1. John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM1,
  2. John O'Grady MD, FRCP, FFPM, FBIRA, MRCPath2
  1. William Wardell,
  2. William Vodra,
  3. Judith K Jones,
  4. Richard N Spivey

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987391.ch22

Book Title

The Textbook of Pharmaceutical Medicine, Fifth Edition

The Textbook of Pharmaceutical Medicine, Fifth Edition

Additional Information

How to Cite

Wardell, W., Vodra, W., Jones, J. K. and Spivey, R. N. (2007) Past Evolution and Future Prospects of the Pharma Industry and its Regulation in the USA, in The Textbook of Pharmaceutical Medicine, Fifth Edition (eds J. P. Griffin and J. O'Grady), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987391.ch22

Editor Information

  1. 1

    Director, Asklepieion Consultancy Ltd., Visiting Professor, University of Surrey Postgraduate Medical School, Former Director, Association of the British Pharmaceutical Industry, London, Formerly Professional Head of the Medicines Division, DHSS, London

  2. 2

    Visiting Professor of Clinical Pharmacology, University of London

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 15 DEC 2005

ISBN Information

Print ISBN: 9780727918406

Online ISBN: 9780470987391

SEARCH

CHAPTER TOOLS

Get PDF (182K)

Keywords:

  • pharmaceutical industry;
  • drug development;
  • kefauver-harris ACT;
  • new drug application;
  • united states

Summary

This chapter contains sections titled:

  • Introduction

  • The Evolution of the FDA and the Pharma Industry from 1962 to 2005

  • Improvements Needed for the Future

  • Conclusions

Get PDF (182K)